Alerts will be sent to your verified email
Verify Email
MEDICAMEQ
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Medicamen Biotech Limited is a pharmaceutical company that manufactures and markets a variety of pharmaceutical formulations globally. Its product range includes tablets, capsules, liquid syrups, and dry syrups.
Medicamen Biotech major competitors are Albert David, Medico Remedies, Shivalik Rasayan, Jenburkt Pharma, Zim Laboratories, Trident Lifeline, Gennex Lab.
Market Cap of Medicamen Biotech is ₹410 Crs.
While the median market cap of its peers are ₹373 Crs.
Medicamen Biotech seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annual Report | FY26 | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
| Earnings Release | |||||||||||||||||||
| Investor Presentation | Sep | Mar Sep Dec | Sep | Mar Jun Sep | Jun | Jun Sep | |||||||||||||
| Conference Call | |||||||||||||||||||
|
Conference Call SummaryCon Call Summary
Powered by Gemini
|
